Series B financing round Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to obtain clinical proof of concept in a “First-in-Man” study as well as CE market approval for Qvanteq’s own novel coronary […]
A portrait of Qvanteq AG was published in the the Swiss journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”. Full article (g).